The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer

Brendon M. Stiles, Amit Bhargava, Prasad S. Adusumilli, Stephen F. Stanziale, Teresa H. Kim, Valerie W. Rusch, Yuman Fong

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences